223 related articles for article (PubMed ID: 28961693)
21. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
[TBL] [Abstract][Full Text] [Related]
22. The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease.
Suárez Ferrer C; Abadía Barno M; Martín Arranz E; Jochems A; García Ramírez L; Poza Cordón J; Jaquotot Herranz M; Cerpa Arencibia A; Martín Arranz MD
Rev Esp Enferm Dig; 2019 Oct; 111(10):744-749. PubMed ID: 31476872
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
[TBL] [Abstract][Full Text] [Related]
24. Correlation between Serological Biomarkers and Disease Activity in Patients with Inflammatory Bowel Disease.
Xu M; Cen M; Chen X; Chen H; Liu X; Cao Q
Biomed Res Int; 2019; 2019():6517549. PubMed ID: 31950048
[TBL] [Abstract][Full Text] [Related]
25. Soluble CD14 Subtype in Peripheral Blood is a Biomarker for Early Diagnosis of Sepsis.
Zhou W; Rao H; Ding Q; Lou X; Shen J; Ye B; Xiang C
Lab Med; 2020 Nov; 51(6):614-619. PubMed ID: 32382753
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.
Shozushima T; Takahashi G; Matsumoto N; Kojika M; Okamura Y; Endo S
J Infect Chemother; 2011 Dec; 17(6):764-9. PubMed ID: 21560033
[TBL] [Abstract][Full Text] [Related]
27. The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease.
Lerchova T; Hradsky O; Copova I; Potuznikova K; Gonsorcikova L; Bronsky J
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):75-81. PubMed ID: 30908389
[TBL] [Abstract][Full Text] [Related]
28. Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M; Arijs I; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Vermeire S; Opdenakker G
J Crohns Colitis; 2015 Dec; 9(12):1079-87. PubMed ID: 26351381
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers.
Ricanek P; Brackmann S; Perminow G; Lyckander LG; Sponheim J; Holme O; Høie O; Rydning A; Vatn MH;
Scand J Gastroenterol; 2011 Sep; 46(9):1081-91. PubMed ID: 21619483
[TBL] [Abstract][Full Text] [Related]
30. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease.
Pastor Rojo O; López San Román A; Albéniz Arbizu E; de la Hera Martínez A; Ripoll Sevillano E; Albillos Martínez A
Inflamm Bowel Dis; 2007 Mar; 13(3):269-77. PubMed ID: 17206721
[TBL] [Abstract][Full Text] [Related]
31. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
[TBL] [Abstract][Full Text] [Related]
32. Altered serum profile of the interleukin-22 system in inflammatory bowel disease.
Sakemi R; Mitsuyama K; Morita M; Yoshioka S; Kuwaki K; Tokuyasu H; Fukunaga S; Mori A; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Mizoguchi A; Sou S; Torimura T
Cytokine; 2020 Dec; 136():155264. PubMed ID: 32920320
[TBL] [Abstract][Full Text] [Related]
33. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn's disease.
Mitselos IV; Katsanos KH; Tatsioni A; Skamnelos A; Eliakim R; Tsianos EV; Christodoulou DK
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):861-867. PubMed ID: 29697457
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.
de Bruyn M; Arijs I; Wollants WJ; Machiels K; Van Steen K; Van Assche G; Ferrante M; Rutgeerts P; Vermeire S; Opdenakker G
Inflamm Bowel Dis; 2014 Jul; 20(7):1198-207. PubMed ID: 24871805
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide.
Teng X; Yang Y; Liu L; Yang L; Wu J; Sun M; Xu L
Pediatr Res; 2020 Nov; 88(5):792-795. PubMed ID: 32120375
[TBL] [Abstract][Full Text] [Related]
36. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
37. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
38. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
39. Utility of the Serum-Based Endoscopic Healing Index in Monitoring Therapeutic Response in Ulcerative Colitis.
Alsoud D; Ho J; Sabino J; Ferrante M; Vermeire S; Verstockt B
Am J Gastroenterol; 2024 Mar; 119(3):477-485. PubMed ID: 37753938
[TBL] [Abstract][Full Text] [Related]
40. Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.
Noman M; Ferrante M; Bisschops R; De Hertogh G; Van den Broeck K; Rans K; Rutgeerts P; Vermeire S; Van Assche G
J Crohns Colitis; 2017 Sep; 11(9):1085-1089. PubMed ID: 28369329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
